Navigation Links
REGiMMUNE presents enhanced efficacy data in preclinical transplantation models
Date:6/1/2009

Boston, MA June 1, 2009 REGiMMUNE Corporation today announced that its lead product candidate RGI-2001, in combination with a low-dose of Sirolimus, demonstrated enhanced efficacy in transplantation tolerance induction in models of skin transplantation and acute Graft-versus-Host disease (GvHD). This data is being presented today in a poster titled "Donor-Specific Tolerance Induction by a Liposomal Formulation of KRN7000 (RGI-2001) Alone and in Combination with Low-Dose Sirolimus" at the 2009 American Transplant Congress being held in Boston.

"We are extremely pleased to present this data," stated Haru Morita, President and Chief Executive Officer of REGiMMUNE. "The study not only demonstrated the efficacy of RGI-2001 in solid organ transplants; it showed the potential of RGI-2001 to induce antigen-specific transplantation tolerance, which is considered a holy grail in transplantation."

KRN7000, a synthetic derivative of alpha-galactosylceramide, is a small molecule that potently activates natural killer T (NKT) cells. RGI-2001 is a proprietary liposomal formulation of KRN7000. RGI-2001 monotherapy has shown to induce antigen-specific immune suppression by inducing regulatory T cells (Tregs). Tregs are believed to play a central role in inducing and maintaining immune tolerance. The study was designed to evaluate the efficacy of RGI-2001 in combination with Sirolimus in transplantation tolerance induction in mouse models.

Study Results

Pharmacological induction of alloantigen-specific tolerance is expected to provide significant clinical benefits in organ transplantation and bone marrow transplantation. The REGiMMUNE study concluded that the addition of a subtherapeutic dose of Sirolimus enhanced the efficacy of RGI-2001 in both models. The combination treatment significantly prolonged the survival of grafts in the skin transplant model over Sirolimus single treatment. Likewise, GvHD mortality was reduced
'/>"/>

Contact: Debra Bannister
530-676-8001
REGiMMUNE
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. REGiMMUNE receives $12 million in grants to develop transplant and allergy drugs
2. Biolex presents Locteron US Phase 2a hepatitis C data at EASL
3. GSA special paper presents new studies of Western US earth motion
4. AIUM Presents 2009 Joseph H. Holmes Pioneer Awards
5. AIUM presents 2009 Memorial Hall of Fame awards
6. AIUM presents 2009 Distinguished Sonographer award
7. AIUM presents 2009 William J. Fry Memorial Lecture award
8. Stevens Center for Science Writings presents: Ravens at the Feast, with Bernd Heinrich, April 1
9. Understanding soil carbon sequestration: New book presents key concepts
10. World Congress on Osteoporosis 2010 presents outstanding scientific program
11. New manual presents robust, state-of-the-art proteomics methods for teaching and research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...vember 2009 issue of the journal GENETICS ( http...y of genes (1-aminocyclopropane-1-carboxylate synt... of ethylene. This gas affects many aspects of pla...dation for future genetic manipulation that could ... thrive in difficult terrain, increase yields, and...
(Date:11/20/2009)...tists from the Marine Biogeochemistry and Geology ...ratory (NRL) organized and led a team of universit...n to initiate methane hydrate exploration in the B... sediment contribution to Arctic climate change. ,... as a research platform, three cross-shelf transec...
(Date:11/20/2009)...ossess an ingenious mechanism for preventing oxyge...is is the new finding of a team of biologists that...search institute in Flanders, Belgium, connected t...ade this discovery by modifying the DNA of the int...this model organism, they have uncovered the exist...
Breaking Biology News(10 mins):It's a gas: New discovery may lead to heartier, high-yielding plants 2International expedition investigates climate change, alternative fuels in Arctic 2Biologists discover bacterial defense mechanism against aggressive oxygen 2Photos 3A The Makers of LISTERINE 28R 29 and REACH 28R 29 TOTAL CARE Products Unveil a New Laugh Out Loud Book Benefiting the National Childrens Oral 57494 1Photos 3A The Makers of LISTERINE 28R 29 and REACH 28R 29 TOTAL CARE Products Unveil a New Laugh Out Loud Book Benefiting the National Childrens Oral 57494 2Photos 3A The Makers of LISTERINE 28R 29 and REACH 28R 29 TOTAL CARE Products Unveil a New Laugh Out Loud Book Benefiting the National Childrens Oral 57494 3Cyberonics to Present at Maxim Group Growth Conference 57492 1Cyberonics to Present at Maxim Group Growth Conference 57492 2Zargis Receives FDA Clearance for Signal X6 Telemedicine Device 3B OK Allows Delivery to US Army 57490 1Zargis Receives FDA Clearance for Signal X6 Telemedicine Device 3B OK Allows Delivery to US Army 57490 2
...eight in the thighs and backside have been told th...eart disease than apple-shaped people who carry fa...researchers at Washington University School of Med...don,t completely explain risk. , In two studies, ...l key to insulin resistance, cholesterol abnormali...
...unamis over the past four years is not enough to s... an international group of earthquake researchers ...e journal Nature . , The first of the recent gre...produced the most widespread and destructive tsuna...as the rupture of a 1600-km-long piece of the Sund...
...Springer as of January 2009. The official journal ...iously published by Wiley-Blackwell, is respected ...pplied research articles in a broad range of subje...hed in English six times a year, Fisheries Scienc...a wide array of topics in both marine and freshwat...
Other Biology News:Apple or pear shape is not main culprit to heart woes -- it's liver fat 2September 2007 Sumatran earthquakes research findings 2September 2007 Sumatran earthquakes research findings 3
(Date:11/20/2009)...swire/ -- Veridiam (www.veridiam.com) won the pres...gory at the 2009 Workplace Excellence Awards. The ...Human Resources Management and recognize innovativ... Veridiam was one of nine winners, selected from m... at the recent awards ceremony. San Diego-based Ve...
(Date:11/20/2009)... Novavax, Inc. (Nasdaq: ...rwritten public offering of 6,800,000 shares of it...er share. The approximately $21 million of net pr... and commissions, will be used for preclinical stu..., internal research and development programs, work...
(Date:11/20/2009)...ewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI...Ninth Circuit Court of Appeals reversed a U.S. Dis...owed to pursue all of its claims against The Lash ... for trial. CTI filed a complaint against The Las...nsultant for CTI,s product TRISENOX, in 2007 seeki...
(Date:11/20/2009)...LEDO recently announced that Dr. Dominique Hebraul...Process Analytical Technology (PAT) in Green Chemi...009. , (PRWEB) November 2...cal Technology (PAT) in Green Chemistry and Green ...ical Technology (PAT) case studies will be present...
Breaking Biology Technology:Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Novavax Prices Public Offering of Common Stock 2Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2
...mance Excellence Promotes Competitiveness with ...RISBURG, Pa., Aug. 20 Five Pennsylvania,organizat..., and results by,the Keystone Alliance for Perform...erence on September 6-7, 2007 in Harrisburg, PA. ...receive KAPE awards are: -- Advent Design Corpora...
...0 IsoTis, Inc.,(NASDAQ: ISOT ) ("IsoTis"), an or...ived a letter dated August 15, 2007 from the US Fo...ccell Family of Products for,marketing in the US a...Products includes Accell 100, Accell Connexus and,...product that is not,currently marketed. The produc...
...rmo Fisher,Scientific Inc. (NYSE: TMO ) announced...Marijn E. Dekkers, president and chief executive,o... Securities and Exchange,Commission (SEC) Rule 10b...,Dekkers, who exercised options for and sold 300,0...lan for the future sale of up to an additional,780...
Other Biology Technology:KAPE to Honor High-Performing Pennsylvania Organizations 2IsoTis Receives FDA Clearance for Accell Family of Products 2IsoTis Receives FDA Clearance for Accell Family of Products 3IsoTis Receives FDA Clearance for Accell Family of Products 4Thermo Fisher Scientific Executive Officers Adopting SEC Rule 10b5-1 Trading Programs 2
...e is the most thoroughly characterized enzyme avai...all utility and efficacy. , Its thermal activity... It is QC tested to guarantee reproducible results...a ultra-pure, gelatin-free, thermostable, recombin...
Taq DNA Polymerase (Thermus aquaticus) from GE Healthcare, formerly Amersham Biosciences
... is a versatile and easy-to use enzyme, with power... DNA Polymerase is prepared from a recombinant clo...rase I gene from Thermococcus litoralis. The enzym...e activity. Its inherent 3'-5' proofreading activi...
Aspergillus-directed IgG EIA Kit from Alpco Diagnostics
Biology Products: